Code | 23089 | ||||||||||
MA number | 29/0659/10-S | ||||||||||
Product Form: | tbl flp 30x800 mg (blis. PVC/PVDC) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | National | ||||||||||
Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - known active substance |
MA issued: | 23.09.2010 |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
SPC: | SPC_BRUFEN RETARD 800 mg_04.2024.pdf |
PIL: | PIL_BRUFEN RETARD 800 mg_04.2024.pdf |
Safety feature | Yes |
Data update: | 16.04.2018 |